About
David Gallagher is a Partner and European and UK Patent Attorney in J A Kemp’s Biotechnology and Life Sciences group, based in the Cambridge office. He handles drafting, filing and prosecution of patent applications for therapeutic antibodies and peptides, diagnostics, recombinant enzymes and host cells, vaccines and agri-food biotechnologies, and has experience with EPO oppositions, international prosecution and freedom-to-operate reports.
Practice areas
Intellectual PropertyPatentsBiotechnology & Life Sciences
Office
Expertise
Therapeutic Antibodies & PeptidesDiagnostic MethodsRecombinant Enzymes & Host CellsVaccinesAnti-cancer BiologicsAgri-food Biotechnology (recombinant yeasts, fungi & bacteria for fermentation and plant care)Probiotics & PrebioticsPatent Prosecution & Opposition ProceedingsFreedom-to-Operate ReportsInternational Patent Prosecution (Africa, South America, Eurasia)
Education
- University of Oxford, Master’s Degree in Biochemistry
- University of Cambridge, PhD in Structural Biology
Admissions
- European Patent Attorney
- UK Patent Attorney
- Fellow of the Chartered Institute of Patent Attorneys (CIPA)
- Member of the Institute of Professional Representatives before the European Patent Office (EPI)